Switching from Multiple Insulin Injections to a Fixed Combination of Degludec and Liraglutide in Patients with Type 2 Diabetes Mellitus: Results from the Simplify Study After 6 Months

INTRODUCTION: This study aimed to evaluate the effectiveness and safety of switching from basal bolus insulin treatment (BBIT) to a fixed combination of insulin degludec and liraglutide (IDegLira) in patients with type 2 diabetes mellitus (T2DM) who had preserved insulin secretion but inadequate glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinka, Emil, Dravecká, Ingrid, Tkáč, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363096/
https://www.ncbi.nlm.nih.gov/pubmed/37402960
http://dx.doi.org/10.1007/s13300-023-01435-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363096/
https://www.ncbi.nlm.nih.gov/pubmed/37402960
http://dx.doi.org/10.1007/s13300-023-01435-z

Ejemplares similares